The company hopes to submit its lead drug later this year for FDA approval. What these 3 Bay Area biotech companies did to ...

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

Merck submitted a nonbinding offer for the smaller biotech earlier in the year, according to a media report citing people ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

A new report from Pitchbook suggests we’re in for a period of more sustainable investing, with VC firms continuing to create ...

The next big test is whether using Pluvicto can delay the advancement of prostate cancer enough to delay chemical castration, ...

Protein degradation company Plexium has laid off staff as part of a realignment to support the company’s pipeline, which is ...

Even after scrapping its lead obesity candidate due to liver toxicity, BioAge Labs is not shying away from the weight loss ...

London-based Ellipses Pharma is close to securing funding in a round designed to be the last before a stock market flotation ...

Regencell's stock soared 17,000% fueled by speculation, despite no revenue or clinical progress. Read why I think the RGC ...

Jefferies has predicted more small tuck-in deals to come, as biotechs struggle to access capital despite key clinical ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...